These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 22544675)

  • 21. Dynamical properties of a minimally parameterized mathematical model for metronomic chemotherapy.
    Schättler H; Ledzewicz U; Amini B
    J Math Biol; 2016 Apr; 72(5):1255-80. PubMed ID: 26089097
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dual Metronomic Chemotherapy with Nab-Paclitaxel and Topotecan Has Potent Antiangiogenic Activity in Ovarian Cancer.
    Previs RA; Armaiz-Pena GN; Lin YG; Davis AN; Pradeep S; Dalton HJ; Hansen JM; Merritt WM; Nick AM; Langley RR; Coleman RL; Sood AK
    Mol Cancer Ther; 2015 Dec; 14(12):2677-86. PubMed ID: 26516159
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Metronomic chemotherapy in cancer treatment: new wine in an old bottle.
    Wu HL; Zhou HX; Chen LM; Wang SS
    Theranostics; 2024; 14(9):3548-3564. PubMed ID: 38948068
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A feasibility trial of antiangiogenic (metronomic) chemotherapy in pediatric patients with recurrent or progressive cancer.
    Kieran MW; Turner CD; Rubin JB; Chi SN; Zimmerman MA; Chordas C; Klement G; Laforme A; Gordon A; Thomas A; Neuberg D; Browder T; Folkman J
    J Pediatr Hematol Oncol; 2005 Nov; 27(11):573-81. PubMed ID: 16282886
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Angiogenesis and chemotherapy resistance: optimizing chemotherapy scheduling using mathematical modeling.
    Bodzioch M; Bajger P; Foryś U
    J Cancer Res Clin Oncol; 2021 Aug; 147(8):2281-2299. PubMed ID: 34050795
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metronomic oral topotecan with pazopanib is an active antiangiogenic regimen in mouse models of aggressive pediatric solid tumor.
    Kumar S; Mokhtari RB; Sheikh R; Wu B; Zhang L; Xu P; Man S; Oliveira ID; Yeger H; Kerbel RS; Baruchel S
    Clin Cancer Res; 2011 Sep; 17(17):5656-67. PubMed ID: 21788355
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase II study of metronomic chemotherapy for recurrent malignant gliomas in adults.
    Kesari S; Schiff D; Doherty L; Gigas DC; Batchelor TT; Muzikansky A; O'Neill A; Drappatz J; Chen-Plotkin AS; Ramakrishna N; Weiss SE; Levy B; Bradshaw J; Kracher J; Laforme A; Black PM; Folkman J; Kieran M; Wen PY
    Neuro Oncol; 2007 Jul; 9(3):354-63. PubMed ID: 17452651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Metronomic chemotherapy in 2011: update and perspectives].
    Benbrahim Z; Massard C; El Mesbahi O
    Bull Cancer; 2011 Dec; 98(12):1447-54. PubMed ID: 22146261
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Enhanced antitumor and anti-angiogenic effects of metronomic Vinorelbine combined with Endostar on Lewis lung carcinoma.
    Qin RS; Zhang ZH; Zhu NP; Chen F; Guo Q; Hu HW; Fu SZ; Liu SS; Chen Y; Fan J; Han YW
    BMC Cancer; 2018 Oct; 18(1):967. PubMed ID: 30305062
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metronomics: towards personalized chemotherapy?
    André N; Carré M; Pasquier E
    Nat Rev Clin Oncol; 2014 Jul; 11(7):413-31. PubMed ID: 24913374
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metronomic Chemotherapy for Pediatric Refractory Solid Tumors: A Retrospective Single-center Study.
    Sakurai Y; Iwasaki F; Hirose A; Matsumoto N; Miyagawa N; Keino D; Yokosuka T; Hamanoue S; Yanagimachi M; Shiomi M; Goto S; Tanaka M; Tanaka Y; Nozawa K; Goto H
    J Pediatr Hematol Oncol; 2024 Jul; 46(5):233-240. PubMed ID: 38691057
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metronomic dosing of chemotherapy: applications in pediatric oncology.
    Stempak D; Seely D; Baruchel S
    Cancer Invest; 2006; 24(4):432-43. PubMed ID: 16777697
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metronomic therapy concepts in the management of adrenocortical carcinoma.
    Berruti A; Sperone P; Bellini E; Daffara F; Perotti P; Ardito A; Saini A; Terzolo M
    Horm Cancer; 2011 Dec; 2(6):378-84. PubMed ID: 21971765
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Enhanced anti-tumor and anti-angiogenic effects of metronomic cyclophosphamide combined with Endostar in a xenograft model of human lung cancer.
    Wang R; Qin S; Chen Y; Li Y; Chen C; Wang Z; Zheng R; Wu Q
    Oncol Rep; 2012 Aug; 28(2):439-45. PubMed ID: 22641525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metronomic chemotherapy combined with endocrine therapy: are we challenging some dogmas?
    Caparica R; De Angelis C; Fêde Â; Werutsky G; de Azambuja E
    Expert Rev Anticancer Ther; 2020 Jul; 20(7):563-573. PubMed ID: 32536212
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antiangiogenesis and vascular disrupting agents in cancer: circumventing resistance and augmenting their therapeutic utility.
    Close A
    Future Med Chem; 2016; 8(4):443-62. PubMed ID: 26933926
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiangiogenic potency of various chemotherapeutic drugs for metronomic chemotherapy.
    Drevs J; Fakler J; Eisele S; Medinger M; Bing G; Esser N; Marmé D; Unger C
    Anticancer Res; 2004; 24(3a):1759-63. PubMed ID: 15274352
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Postsurgical adjuvant tumor therapy by combining anti-angiopoietin-2 and metronomic chemotherapy limits metastatic growth.
    Srivastava K; Hu J; Korn C; Savant S; Teichert M; Kapel SS; Jugold M; Besemfelder E; Thomas M; Pasparakis M; Augustin HG
    Cancer Cell; 2014 Dec; 26(6):880-895. PubMed ID: 25490450
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of vascular normalization in benefit from metronomic chemotherapy.
    Mpekris F; Baish JW; Stylianopoulos T; Jain RK
    Proc Natl Acad Sci U S A; 2017 Feb; 114(8):1994-1999. PubMed ID: 28174262
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of schedule-dependent metronomic S-1 chemotherapy in human oral squamous cell carcinoma cells.
    Ferdous T; Harada K; Kin T; Harada T; Ueyama Y
    Int J Oncol; 2013 Jul; 43(1):271-9. PubMed ID: 23695365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.